Header Logo

Lydia Usha

Concepts (174)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.


Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Breast Neoplasms
14
2022
409
4.170
Why?
Ovarian Neoplasms
8
2021
72
3.100
Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
3
2021
11
1.810
Why?
Germ-Line Mutation
4
2021
14
1.590
Why?
Genes, BRCA1
3
2020
12
1.410
Why?
DNA-Binding Proteins
4
2021
276
1.170
Why?
Genes, BRCA2
3
2020
10
1.130
Why?
Endometrial Neoplasms
2
2021
13
0.870
Why?
Genes, p53
3
2020
18
0.860
Why?
Genetic Testing
2
2021
57
0.850
Why?
Phthalazines
2
2020
6
0.840
Why?
Female
24
2022
15212
0.840
Why?
Piperazines
2
2020
85
0.780
Why?
Mutation
4
2021
348
0.770
Why?
Cystadenocarcinoma, Serous
1
2021
4
0.740
Why?
Fanconi Anemia Complementation Group Proteins
1
2021
1
0.740
Why?
RNA Helicases
1
2021
2
0.740
Why?
Poly(ADP-ribose) Polymerase Inhibitors
1
2020
5
0.680
Why?
Neoplasm Recurrence, Local
4
2021
206
0.670
Why?
Hematopoiesis
1
2018
11
0.600
Why?
Chimerism
1
2018
4
0.600
Why?
BRCA1 Protein
1
2018
4
0.600
Why?
Li-Fraumeni Syndrome
1
2018
3
0.600
Why?
Nitriles
2
2017
14
0.600
Why?
BRCA2 Protein
1
2018
4
0.600
Why?
Humans
24
2022
27072
0.590
Why?
Aromatase Inhibitors
1
2017
8
0.570
Why?
Hepatitis, Autoimmune
1
2017
5
0.570
Why?
Triazoles
1
2017
29
0.560
Why?
Neoplasms, Multiple Primary
1
2017
39
0.550
Why?
Stomach Neoplasms
1
2017
34
0.540
Why?
Receptor, ErbB-2
3
2014
51
0.530
Why?
Early Detection of Cancer
2
2022
102
0.520
Why?
Adult
10
2020
7831
0.490
Why?
Estrogens
1
2015
25
0.490
Why?
False Positive Reactions
1
2015
34
0.490
Why?
Antineoplastic Agents, Hormonal
1
2015
18
0.490
Why?
Estradiol
1
2015
53
0.490
Why?
Immunoassay
1
2015
38
0.480
Why?
Protein Kinase Inhibitors
2
2014
53
0.470
Why?
Radiation-Sensitizing Agents
1
2014
5
0.460
Why?
Middle Aged
11
2021
8923
0.420
Why?
Aged
8
2021
8997
0.400
Why?
Cell Line, Tumor
4
2021
256
0.400
Why?
Inflammatory Breast Neoplasms
1
2012
4
0.400
Why?
Ribonucleotide Reductases
1
2012
1
0.400
Why?
Platinum
1
2012
4
0.400
Why?
Biopsy
4
2017
201
0.390
Why?
Enzyme Inhibitors
1
2012
114
0.380
Why?
Cell Proliferation
4
2021
175
0.380
Why?
Drug Resistance, Neoplasm
1
2012
69
0.370
Why?
Genetic Predisposition to Disease
4
2022
381
0.360
Why?
Peritoneal Neoplasms
1
2011
6
0.360
Why?
Indoles
1
2011
32
0.360
Why?
Protein Kinase C
1
2011
48
0.360
Why?
DNA Mismatch Repair
2
2021
8
0.320
Why?
DNA Topoisomerases, Type II
1
2008
3
0.310
Why?
Genes, erbB-2
1
2008
7
0.310
Why?
Antigens, Neoplasm
1
2008
41
0.300
Why?
Antibodies, Monoclonal, Humanized
3
2021
85
0.300
Why?
Carcinoma, Ductal, Breast
3
2015
33
0.290
Why?
Mismatch Repair Endonuclease PMS2
2
2017
5
0.270
Why?
Neoplasm Staging
2
2017
363
0.250
Why?
Retrospective Studies
4
2022
3538
0.250
Why?
Cancer Survivors
1
2022
12
0.200
Why?
Biomarkers, Tumor
2
2017
205
0.200
Why?
Antineoplastic Agents
2
2019
198
0.200
Why?
Coculture Techniques
1
2021
29
0.190
Why?
Fibroblasts
1
2021
58
0.190
Why?
Sequence Analysis, DNA
1
2021
58
0.190
Why?
Precision Medicine
1
2021
26
0.190
Why?
High-Throughput Nucleotide Sequencing
1
2021
44
0.190
Why?
Genomics
1
2021
64
0.180
Why?
Checkpoint Kinase 2
1
2020
8
0.180
Why?
Apoptosis
1
2021
213
0.170
Why?
Animals
2
2021
3642
0.170
Why?
Fanconi Anemia Complementation Group N Protein
1
2019
1
0.170
Why?
Folic Acid Deficiency
1
2019
7
0.160
Why?
Pilot Projects
1
2020
420
0.160
Why?
Neoplasm Metastasis
3
2014
107
0.160
Why?
Lymphatic Metastasis
2
2012
93
0.160
Why?
Cadherins
2
2017
34
0.160
Why?
Pedigree
1
2017
65
0.140
Why?
Antigens, CD
1
2017
50
0.140
Why?
Neoplasms
1
2019
237
0.130
Why?
Receptors, Estrogen
2
2015
65
0.130
Why?
MutL Protein Homolog 1
1
2016
2
0.130
Why?
DNA Repair Enzymes
1
2016
7
0.130
Why?
MutS Homolog 2 Protein
1
2016
3
0.130
Why?
Adenosine Triphosphatases
1
2016
8
0.130
Why?
Microsatellite Instability
1
2016
11
0.130
Why?
Immunohistochemistry
1
2017
366
0.130
Why?
Liver
1
2017
145
0.130
Why?
Adaptor Proteins, Signal Transducing
1
2016
64
0.130
Why?
Nuclear Proteins
1
2016
89
0.120
Why?
Chromatography, Liquid
1
2015
23
0.120
Why?
Tandem Mass Spectrometry
1
2015
20
0.120
Why?
Postmenopause
1
2015
54
0.120
Why?
Phosphatidylinositol 3-Kinases
2
2014
44
0.120
Why?
Ribosomal Protein S6 Kinases, 70-kDa
1
2014
2
0.120
Why?
Hydroxybutyrates
1
2014
7
0.120
Why?
Aniline Compounds
1
2014
35
0.120
Why?
Cell Cycle
1
2014
34
0.120
Why?
Aged, 80 and over
2
2020
4777
0.110
Why?
Colitis, Ulcerative
1
2014
59
0.110
Why?
Fluorescent Antibody Technique
1
2013
55
0.110
Why?
Anti-Inflammatory Agents
1
2014
79
0.110
Why?
Blotting, Western
1
2013
147
0.110
Why?
Tumor Necrosis Factor-alpha
1
2014
189
0.100
Why?
Cell Movement
1
2013
80
0.100
Why?
Cell Differentiation
1
2013
137
0.100
Why?
Mice, Transgenic
1
2013
219
0.100
Why?
Axilla
1
2012
14
0.100
Why?
Deoxycytosine Nucleotides
1
2012
1
0.100
Why?
Thiosemicarbazones
1
2012
1
0.100
Why?
Immunoblotting
1
2012
54
0.100
Why?
Gynecology
1
2012
9
0.100
Why?
Pyridines
1
2012
33
0.100
Why?
DNA Damage
1
2012
29
0.100
Why?
Cells, Cultured
1
2013
520
0.100
Why?
Histones
1
2012
32
0.100
Why?
Cell Survival
1
2012
121
0.100
Why?
Lymph Nodes
1
2012
72
0.100
Why?
Medical Oncology
1
2012
44
0.090
Why?
Neoplasms, Glandular and Epithelial
1
2011
2
0.090
Why?
Protein Kinase C beta
1
2011
8
0.090
Why?
Class I Phosphatidylinositol 3-Kinases
1
2011
9
0.090
Why?
PTEN Phosphohydrolase
1
2011
7
0.090
Why?
Family
1
2012
103
0.090
Why?
Vascular Endothelial Growth Factor A
1
2011
75
0.090
Why?
Proto-Oncogene Proteins c-akt
1
2011
57
0.090
Why?
Mice
1
2013
1395
0.080
Why?
Poly-ADP-Ribose Binding Proteins
1
2008
3
0.080
Why?
Chromosomes, Human, Pair 17
1
2008
7
0.080
Why?
Gene Dosage
1
2008
19
0.080
Why?
Gene Amplification
1
2008
21
0.080
Why?
Gene Deletion
1
2008
42
0.080
Why?
Chromosomes, Human, Pair 10
1
2007
5
0.070
Why?
Chromosomes, Human, Pair 3
1
2007
7
0.070
Why?
Chromosomes, Human, Pair 1
1
2007
8
0.070
Why?
Antibodies, Monoclonal
1
2007
177
0.060
Why?
Prognosis
1
2008
785
0.060
Why?
Carcinoma, Lobular
1
2005
23
0.060
Why?
Treatment Outcome
1
2012
3485
0.050
Why?
Breast Density
1
2022
4
0.050
Why?
Mammography
1
2022
47
0.050
Why?
Mass Screening
1
2022
167
0.050
Why?
Breast Neoplasms, Male
1
2019
11
0.040
Why?
Internationality
1
2019
21
0.040
Why?
Folic Acid
1
2019
21
0.040
Why?
Risk
1
2019
204
0.040
Why?
Pancreatic Neoplasms
1
2019
93
0.040
Why?
Magnetic Resonance Imaging
1
2022
1112
0.040
Why?
Age Factors
1
2019
766
0.030
Why?
Butadienes
1
2014
1
0.030
Why?
Crotonates
1
2014
3
0.030
Why?
Toluidines
1
2014
3
0.030
Why?
Chromones
1
2014
7
0.030
Why?
Isoxazoles
1
2014
6
0.030
Why?
Morpholines
1
2014
12
0.030
Why?
Pyrazines
1
2014
11
0.030
Why?
Feedback, Physiological
1
2014
13
0.030
Why?
Receptor, IGF Type 1
1
2014
21
0.030
Why?
Gene Knockdown Techniques
1
2014
45
0.030
Why?
MAP Kinase Signaling System
1
2014
36
0.030
Why?
Carcinoembryonic Antigen
1
2014
5
0.030
Why?
Adalimumab
1
2014
16
0.030
Why?
Diarrhea
1
2014
34
0.030
Why?
Imidazoles
1
2014
59
0.030
Why?
Mastectomy
1
2014
36
0.030
Why?
Tomography, X-Ray Computed
1
2014
683
0.020
Why?
Trastuzumab
1
2007
26
0.020
Why?
Receptors, Progesterone
1
2005
26
0.020
Why?
Male
1
2019
14772
0.010
Why?
Usha's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (174)
Explore
_
Co-Authors (21)
Explore
_
Similar People (60)
Explore
_
Same Department Expand Description
Explore
_